Home » Topics » Regulatory » Patents

Patents
RSS

Bayer patents anticancer compounds

Jan. 12, 2017

Apodemus prepares and tests PI4Kbeta inhibitors

Jan. 11, 2017

Actelion Pharmaceuticals reveals NOX4 inhibitors for fibrosis

Jan. 11, 2017

Novartis describes SHP-2 inhibitors

Jan. 11, 2017

Bayer patents GLUT-1 inhibitors

Jan. 11, 2017

Jiangsu Hengrui Medicine patent reports SERDs

Jan. 11, 2017

Ramot describes drug conjugates for cancer

Jan. 11, 2017

KRICT reports PI3Kdelta inhibitors

Jan. 10, 2017

Pfizer describes BET protein inhibitors for cancer

Jan. 10, 2017

University College Dublin patents prostanoid TP antagonists

Jan. 10, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...